Surface Engineered Biomaterials to Control Inflammation. The overarching aim of this project is to provide a mechanistic understanding of how surface nanotopography affects inflammatory responses. Experimental evidence demonstrates that engineered surface nanotopography in combination with surface chemistry downregulates the expression of proinflammatory cytokines from primary macrophages. The significance of these findings is that it may be possible to engineer the nanotopography of a biomedica ....Surface Engineered Biomaterials to Control Inflammation. The overarching aim of this project is to provide a mechanistic understanding of how surface nanotopography affects inflammatory responses. Experimental evidence demonstrates that engineered surface nanotopography in combination with surface chemistry downregulates the expression of proinflammatory cytokines from primary macrophages. The significance of these findings is that it may be possible to engineer the nanotopography of a biomedical device surface in a manner which leads to a desired and predictable level of inflammation and subsequent foreign body reaction (FBR) medical implants and tissue engineering constructs.Read moreRead less
Virtual testing of orthopaedic devices as part of the design and development process: strategies to account for patient and surgical variability. Novel computational tools will be developed through this project to help account for patient and surgical variability in the design of orthopaedic implants, such as hip and knee replacements and spinal products. These tools will reduce the design time, give greater insight in implant performance and ultimately lead to safer implants with improved longe ....Virtual testing of orthopaedic devices as part of the design and development process: strategies to account for patient and surgical variability. Novel computational tools will be developed through this project to help account for patient and surgical variability in the design of orthopaedic implants, such as hip and knee replacements and spinal products. These tools will reduce the design time, give greater insight in implant performance and ultimately lead to safer implants with improved longevity.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC170100030
Funder
Australian Research Council
Funding Amount
$4,133,659.00
Summary
ARC Training Centre in Cognitive Computing for Medical Technologies. The ARC Training Centre in Cognitive Computing for Medical Technologies aims to create a workforce that is expert in developing, applying and interrogating cognitive computing technologies in data-intensive medical contexts. This will facilitate the next generation of data-driven and machine learning-based medical technologies. The Centre will provide a world-class industry-driven research training environment for PhD students ....ARC Training Centre in Cognitive Computing for Medical Technologies. The ARC Training Centre in Cognitive Computing for Medical Technologies aims to create a workforce that is expert in developing, applying and interrogating cognitive computing technologies in data-intensive medical contexts. This will facilitate the next generation of data-driven and machine learning-based medical technologies. The Centre will provide a world-class industry-driven research training environment for PhD students and postdoctoral researchers. These researchers will lead the medical technology industry into a new era of data-driven personalised and precision medical devices and applications. The Centre will result in the development of capabilities in the core technologies of machine learning and the practical application of cognitive computing in the area of health.Read moreRead less
Electrochemical biosensors for detection of cardiac disease markers in blood. Cardiovascular diseases leading to heart failure have a prevalence of over 16 per cent in Australia. The social, economic and health burden is higher than for any other disease group. Hence, it is critically important to develop fit-for-purpose sensors of known cardiac biomarkers, which alert patients and clinicians of the risk of imminent heart failure.
A nanoengineered solution to drug delivery in bone. This project presents an exciting new approach of applying nanotechnology to bone research. By combining our expertise in nanoengineering of new materials, mathematical modelling and bone biology, this project will result in a well-characterised model for drug delivery into bone and lead to a new therapeutic approach for treating bone diseases.